The civic record
Read. Follow. Verify.Congressional Hearing on the Trump Administration's Drug Crisis Response
Record date · January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
The House Committee on Oversight and Reform held a hearing on March 7, 2019, to evaluate the federal government's strategy for addressing the national drug overdose crisis. The session included testimony from federal officials and experts regarding the scope of the epidemic and the effectiveness of current policy responses.
This hearing serves as a formal oversight mechanism to review federal drug policy and the allocation of resources for the Office of National Drug Control Policy, which impacts national public health strategies and funding for local drug trafficking task forces.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Office of National Drug Control Policy
The agency's policies and funding were subject to congressional review and oversight during this hearing.
General Public
The hearing addresses national public health strategies regarding drug overdoses, which impact healthcare and law enforcement services nationwide.
Key Facts
- The hearing took place on March 7, 2019, in the Rayburn House Office Building.
- In 2017, more than 70,000 people died from drug overdoses in the United States.
- The committee previously passed bipartisan legislation to reauthorize the Office of National Drug Control Policy.
- The hearing included testimony from the Office of National Drug Control Policy, the Government Accountability Office, and the Houston High Intensity Drug Trafficking Area.
Show all 5 facts
- Several documents were entered into the record, including the 2018 Houston HIDTA Threat Assessment Report and various articles on the opioid crisis.
Frequently Asked Questions
What was the purpose of this hearing?
Who testified at the hearing?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Bipartisan focus on drug policy
The hearing highlights a rare instance of bipartisan cooperation in the 116th Congress regarding the reauthorization of the Office of National Drug Control Policy.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools
